Anebulo Pharmaceuticals Inc (ANEB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,503 | -2,626 | -1,553 | -30,253 | -1,141 |
| Accounts receivable | N/A | N/A | N/A | 4 | 4 |
| Accounts payable and accrued liabilities | -27 | -67 | 384 | 110 | 82 |
| Other Working Capital | 811 | 521 | 741 | -1,445 | -318 |
| Other Operating Activity | 281 | 196 | -350 | 26,714 | -1 |
| Operating Cash Flow | $-3,438 | $-1,977 | $-778 | $-4,871 | $-1,374 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -201 | -201 |
| Common Stock Issued | N/A | N/A | N/A | 20,605 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 1,429 | 1,857 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $21,832 | $1,656 |
| Beginning Cash Position | 19,986 | 19,986 | 19,986 | 3,025 | 3,025 |
| End Cash Position | 16,548 | 18,009 | 19,208 | 19,986 | 3,307 |
| Net Cash Flow | $-3,438 | $-1,977 | $-778 | $16,961 | $282 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,438 | -1,977 | -778 | -4,871 | -1,374 |
| Free Cash Flow | -3,438 | -1,977 | -778 | -4,871 | -1,374 |